Occult hepatitis B in HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 3, 2004, Pages 869-875

  Shire, Norah J ^a   Rouster, Susan D ^a   Rajicic, Natasa ^b   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Epidemiology; HB anticore IgG; Hepatitis B surface antigen; Hepatitis B virus; HIV; Occult; Prevalence; Serologic markers

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; UNITED STATES;

ADULT; ALANINE TRANSAMINASE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES;

EID: 3042854270     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200407010-00015     Document Type: Article

References (49)

1. Fact Sheet WHO/204, Hepatitis B. World Health Organization (WHO) Fact Sheets. Available at: http://www.who.int/inf-fs/en/fact204.html. Accessed April 10, 1993.
2. Scully LJ, Sung H, Pennie R, et al. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol. 1994;44:293-297.
3. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994;343:142-146.
4. Hofer M, Joller-Jemelka HI, Grob PJ, et al. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998;17:6-13.
5. Núñez M, Rios P, Perez-Olmeda M, et al. Lack of "occult" hepatitis B virus infection in HIV-infected patients. AIDS. 2002;16:2099-2101.
6. Rhodes T, Hunter GM, Stimson GV, et al. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour. Addiction. 1996;91:1457-1467.
7. Rodriguez-Mendez ML, Gonzalez-Quintela A, Aguilera A, et al. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Am J Gastroenterol. 2000;95:1316-1322.
8. Mezzelani P, Quaglio G, Venturini L, et al. [The significance of the isolated anti-HBc carrier: a study of 1797 drug addicts. The Intersert Group of Scientific Collaboration.] Recenti Prog Med. 1994;85:419-424.
9. Vazquez-Vizoso F, Eiroa P, Ledo L, et al. HIV infection and isolated detection of anti-HBc. Gastroenterology. 1994;106:823-824.
10. Levine OS, Vlahov D, Brookmeyer R, et al. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis. 1996;173:579-583.
11. Krogsgaard K, Lindhardt BO, Nielson JO, et al. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology. 1987;7:37-41.
12. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med. 1986;105:382-383.
13. Rector WG Jr, Govindarajan S, Horsburgh CR Jr, et al. Hepatic inflammation, hepatitis B replication, and cellular immune function in homosexual males with chronic hepatitis B and antibody to human immunodeficiency virus. Am J Gastroenterol. 1988;83:262-266.
14. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis. 1989;160:577-582.
15. Hadler SC, Judson FN, O'Malley PM, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis. 1991;163:454-459.
16. Gilson RJ, Hawkins AE, Beecham MR, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997;11:597-606.
17. Colin JF, Cazals-Hatem D, Loriot MA, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29:1306-1310.
18. Francisci D, Baldelli F, Papili R, et al. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients. Eur J Epidemiol. 1995;11:123-126.
19. Sanchez-Quijano A, Jauregui JI, Leal M, et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol. 1993;17:288-293.
20. Kellerman SE, Hanson DL, McNaghten AD, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis. 2003;188:571-577.
21. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet. 1997;349:995-996.
22. Bessesen M, Ives D, Condreay L, et al. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis. 1999;28:1032-1035.
23. Coleman PJ, McQuillan GM, Moyer LA, et al. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis. 1998;178:954-959.
24. Lazizi Y, Grangeot-Keros L, Delfraissy JF, et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. J Infect Dis. 1988;158:666-667.
25. Scharschmidt BF, Held MJ, Hollander HH, et al. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med. 1992;117:837-838.
26. Levine OS, Vlahov D, Koehler J, et al. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol. 1995;142:331-341.
27. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995;155:1305-1311.
28. Dimitrakopoulos A, Takou A, Haida A, et al. The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients. J Infect. 2000;40:127-131.
29. Kellerman SE, Hanson DL, McNaghten AD. Incidence of acute hepatitis B (HBV) infection in HIV-infected persons and the impact of HBV vaccination and lamivudine. Paper presented at: 9th Conference on Retroviruses and Opportunistic Infections; February 24-28, 2002; Seattle, WA.
30. Jilg W, Sieger E, Zachoval R, et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol. 1995;23:14-20.
31. Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol. 1991;35:55-59.
32. Ranki M, Schatzl HM, Zachoval R, et al. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology. 1995;21:1492-1499.
33. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001;34:194-203.
34. Chemin I, Zoulim F, Merle P, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001;34:447-454.
35. Kao JH, Chen PJ, Lai MY, et al. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol. 2002;40:4068-4071.
36. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002; ii:479-486.
37. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341:22-26.
38. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837.
39. Shiota G, Oyama K, Udagawa A, et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol. 2000;62:151-158.
40. Koyama H, Nishizawa Y, Kinoshita H, et al. Hepatocellular carcinoma with occult chronic hepatitis: hepatitis B virus as a pathogenetic factor of hepatocellular carcinoma. Osaka City Med J. 1988;34:51-66.
41. Uchida T, Shimojima S, Gotoh K, et al. Pathology of livers infected with "silent" hepatitis B virus mutant. Liver. 1994;14:251-256.
42. Takeuchi M, Fujimoto J, Niwamoto H, et al. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci. 1997;42:2264-2269.
43. Paterlini P, Poussin K, Kew M, et al. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology. 1995;21:313-321.
44. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988;ii:1273-1276.
45. Hoofnagle JH, Seefe LB, Bales ZB, et al. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl JMed. 1978;298:1379-1383.
46. Koziel MJ. The immunopathogenesis of hepatitis B virus infection. In: Schinazi RF SJ, Thomas HC, eds. Therapiesfor Viral Hepatitis. Atlanta, GA: International Medical Press; 1998:53-64.
47. Chung RT, Kim AY, Polsky B. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy. Antivir Chem Chemother. 2001;12(suppl 1):73-91.
48. McMahon BJ, Parkinson AJ, Helminiak C, et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology. 1992;103:590-594.
49. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol. 2000;62:450-455.